WHOOP, a human performance company based in Boston, has raised $575 million in Series G funding, bringing its valuation to $10.1 billion. This is the company’s largest funding round to date and marks a big jump from its previous $3.6 billion valuation.
The funding round was led by Collaborative Fund, with support from 2PointZero Group, Qatar Investment Authority (QIA), Mubadala Investment Company, Abbott, Mayo Clinic, Macquarie Capital, Glade Brook, IVP, Foundry, Accomplice, Affinity Partners, and Bullhound Capital. Other investors include Cristiano Ronaldo, LeBron James, Rory McIlroy, Virgil van Dijk, Reggie Miller, Niall Horan, Karen Wazen, and Shane Lowry.
WHOOP was founded in 2012 by Will Ahmed, an Egyptian-American entrepreneur and former Harvard squash team captain. Ahmed started the company after struggling with chronic overtraining as a student athlete. Without a way to measure his readiness, he often pushed himself too far and faced setbacks.
What started as a research project has grown into a full human performance company. Ahmed now aims to build a health operating system that helps people in their everyday lives.
What does WHOOP offer?
Chronic diseases are on the rise worldwide, but most healthcare systems still focus on treating illness instead of preventing it. New advances in AI and continuous biometric data are enabling proactive care.
WHOOP’s main product is a membership that combines a screenless wearable device with an AI-powered coaching app. The device has no screen by design. Rather than distracting users, WHOOP sends insights straight to the app, which members check more than eight times a day, almost three times as often as users of other screenless wearables.
The platform draws on more than 24 billion hours of physiological data and uses custom AI models to convert raw biometric data into practical, personalised advice. Key features include an FDA-cleared ECG for heart monitoring, a Healthspan tool to track biological age, Blood Pressure Insights for ongoing heart health, Advanced Labs for blood biomarker analysis, and a 14-day battery life that outlasts most competitors.
The platform also gives updates on sleep, recovery, and strain, and offers fitness coaching.
Clinical research shows real results: WHOOP members get over 90 more minutes of exercise each week, sleep an extra 2+ hours per night, and have 10% higher heart rate variability than non-users.
WHOOP’s main competitors in recovery-focused wearables are the Oura Ring, a Finnish smart ring valued at $11 billion, and, more broadly, the Apple Watch and Garmin. WHOOP stands out as the most data-driven, coaching-focused platform, and its position is strengthened by clinical partnerships with organisations such as Mayo Clinic and Abbott that competitors at this scale lack.
The road ahead
The money from the Series G round will help WHOOP expand globally, with plans to enter markets in Europe, the GCC, Latin America, and Asia.
“WHOOP has become one of the most important tools I use to support my long-term health. No other company has created a health platform this powerful that people are proud to wear,” says Cristiano Ronaldo, a WHOOP investor and global ambassador.
